Skip to main content
OpenTrials

Clinical trial condition

Progressive Familial Intrahepatic Cholestasis

Explore clinical trials studying Progressive Familial Intrahepatic Cholestasis. Study availability and eligibility vary by location and protocol.

14 public trials 7 recruiting studies
Refine in advanced search Browse all conditions

Progressive Familial Intrahepatic Cholestasis trial results

Recruiting

A Study of the Effectiveness, Safety and the Long-term Outcomes of Participants With Progressive Familial Intrahepatic Cholestasis (PFIC) Who Take Odevixibat (Bylvay) in China

NCT07588880

Conditions
Cholestasis, progressive familial intrahepatic 1, Progressive Familial Intrahepatic Cholestasis
Locations
  • Capital Children's Medical Center Beijing, China
  • Hunan Children's Hospital Hunan, China
  • Children's Hospital of Fudan University Endocrinology and Metabolism Shanghai, China
View Trial Details
Recruiting

A Study of the Effectiveness, Safety and the Long-term Outcomes of Participants With Progressive Familial Intrahepatic Cholestasis (PFIC) Who Take Odevixibat (Bylvay) in South Korea

NCT07185919

Conditions
Cholestasis, progressive familial intrahepatic 1, Progressive Familial Intrahepatic Cholestasis
Locations
  • Pusan National University Yangsan Hospital Gyeongsang, South Korea
  • Seoul National University Hospital Seoul, South Korea
  • Severance Hospital, Yonsei University Health System Seoul, South Korea
View Trial Details
Recruiting

Long-Term Low-Intervention SafEty and Clinical Outcomes Clinical Study of LivmArli® in Patients With Alagille Syndrome or Progressive Familial Intrahepatic Cholestasis in the European Union (LEAP-EU)

NCT07290257

Conditions
Abnormalities, Multiple, Alagille Syndrome, Bile Duct Diseases, +19 more
Locations
  • Cliniques Universitaires Saint Luc (UCLouvain) Brussels, Belgium
  • University Hospital Gent (UZ Gent) Ghent, Belgium
  • Hospices Civils de Lyon - Hopital Femme Mère Enfant Bron, Auvergne-Rhône-Alpes, France
  • CHU de Toulouse - Hôpital des Enfants Toulouse, Occitanie, France
View all 15 locations
View Trial Details
Recruiting

Long-Term SafEty and Clinical Outcomes of LivmArli in Patients in the United States (LEAP-US)

NCT06193928

Conditions
Abnormalities, Multiple, Alagille Syndrome, Bile Duct Diseases, +13 more
Locations
  • Children's Hospital Los Angeles CHLA Los Angeles, California, United States
  • Section of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics and the Digestive Health Institute, Children's Hospital of Colorado and University of Colorado Aurora, Colorado, United States
  • Children's Healthcare of Atlanta - Emory University School of Medicine Atlanta, Georgia, United States
  • Children's Mercy Kansas City, Department of Gastroenterology, Section of Hepatology Kansas City, Missouri, United States
View Trial Details
Completed

A Study to Evaluate the Safety and Tolerability of Maralixibat in Infant Participants With Cholestatic Liver Diseases Including Progressive Familial Intrahepatic Cholestasis (PFIC) and Alagille Syndrome (ALGS).

NCT04729751

Conditions
Abnormalities, Multiple, Alagille Syndrome, Bile Duct Diseases, +14 more
Locations
  • Children Hospital LA Los Angeles, California, United States
  • University of California - San Francisco San Francisco, California, United States
  • Medstar Georgetown University Hospital Washington D.C., District of Columbia, United States
  • Ochsner Hospital for Children New Orleans, Louisiana, United States
View all 14 locations
View Trial Details
Completed

Long Term Safety & Efficacy Study Evaluating The Effect of A4250 in Children With PFIC

NCT03659916

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +3 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's Hospital Colorado Denver, Colorado, United States
  • Emory University School of Medicine Atlanta, Georgia, United States
  • Riley Hospital for Children - Riley Children's Specialists Indianapolis, Indiana, United States
View all 41 locations
View Trial Details

Related conditions